© The EVERY Company The EVERY Company has secured $55 million in a Series D funding round. This funding will support the company’s expansion into the US market as it scales up its production of precision-fermented egg proteins. The round was led by McWin Capital Partners, with participation from a range of investors including Main Sequence, Bloom8, and Minerva Foods. EVERY’s fermentation-based technology has gained significant attention as an alternative to traditional egg proteins. Its ...
